This website is intended for Medical Professionals only. By using this site you confirm that you are a healthcare professional.

News
Osteoarthritis linked to higher risk of ... Researchers at Lund University in Sweden have investigated the ... (17 Jul 2019)
Higher iron levels may boost heart health – ... In a series of early-stage studies examining genetic data from ... (17 Jul 2019)
Iatrogenic disorders in psychiatry are ... In a paper published in the current issue of Psychotherapy and ... (17 Jul 2019)
High Blood Pressure, Cholesterol in Young ... Increased risk found to be independent of exposure to these risk ... (17 Jul 2019)
One-year course of studies leading to a ... The Centre for Traditional Chinese Medicine of the University of ... (12 Jul 2019)
Monday, 13 May 2019 19:28

Fracture Risk Tool Is Useful in Women with Breast Cancer Initiating Aromatase Inhibitor Therapy Featured

Rate this item
(0 votes)

The FRAX®tool takes into account certain factors to determine the risk of bone fracture in the general population.

In a Journal of Bone and Mineral Research study, the tool was effective at determining fracture risk for women with breast cancer who were treated with aromatase inhibitors, which cause accelerated bone loss, when combined with bone mineral density measurements.
However, the results also question the practice of considering aromatase inhibitors a “secondary cause of osteoporosis” when the FRAX® tool is used without bone mineral density, because this can lead to over estimation of fracture risk. Nonetheless, it is very important to determine fracture risk in women receiving aromatase inhibitor therapy who will most likely experience bone loss during treatment.

“We hope that our data will help to inform clinical guidelines regarding fracture risk assessment in women with breast cancer, and the incorporation of FRAX® in management algorithms of those receiving aromatase inhibitors,” said lead author Dr. William D. Leslie, of the University of Manitoba, in Canada.


Source: Wiley

Full bibliographic information

Performance of FRAX in Women with Breast Cancer Initiating Aromatase Inhibitor Therapy: A Registry-Based Cohort Study. Journal of Bone and Mineral Research. DOI:10.1002/jbmr.3726

Read 213 times Last modified on Tuesday, 14 May 2019 16:01

Latest news

Highlights

Join

Connect with other Medical Professionals on fb in a closed facebook group

Login

Top
We use cookies to improve our website. By continuing to use this website, you are giving consent to cookies being used. More details…